Publication
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic
Maria Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, Moran Dvela-Levitt, Michelle Melanson, Brian T. Chamberlain, Seth L. Alper, Jean Santos, Juan Gutierrez, Ayshwarya Subramanian, Elizabeth Grinkevich, Estefania Reyes Bricio, Choah Kim, Abbe Clark, Andrew Watts, Rebecca Thompson, Jamie Marshall, Juan Lorenzo Pablo, Juliana Coraor, Julie Roignot, Katherine A. Vernon, Keith Keller, Alissa Campbell, Maheswarareddy Emani, Matthew Racette, Silvana Bazua-Valenti, Valeria Padovano, Astrid Weins, Stephen P. McAdoo, Frederick W.K. Tam, Lucienne Ronco, Florence Wagner, George C. Tsokos, Jillian L. Shaw, Anna Greka
June 2020, Cold Spring Harbor Laboratory Press
DOI: 10.1101/2020.06.30.180380